MMM3M
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $2.50Beat
- vs $2.40 expected on Oct 20
- Stock move on it
- +5.78%
- one session
- Typical move
- ±6.6%
- average over 2 reports
- Price
- $186.34
- −1.34% today · $91.8B cap
Past and upcoming reports
2
| Oct 20, 2026 | Sep 30, 2026 | Time not given | $2.40 | Beat$2.50 | +5.78% |
| Jul 21, 2026 | Jun 30, 2026 | Time not given | $2.22 | Beat$2.40 | +7.32% |
After the report
Jul 21, 2026 report
This covers the Jul 21, 2026 report. The Oct 20, 2026 numbers are in the table above.
3M beats Q2 EPS by 5.7%, turnaround narrative gains traction
3M reported Q2 EPS of $2.40, beating the $2.27 consensus by 5.7%. The stock surged 7.3% on the day and continues to trade higher, reflecting growing confidence in the turnaround. Strong operating margins (19.8%) and ROE (72.1%) underscore improving fundamentals, though debt/equity at 4x remains a structural concern.
Reported against expected
BeatBeat: reported EPS $2.40 vs estimated $2.27 (surprise +5.73%).
Guidance
Management's tone indicates accelerating turnaround, with EPS forecast next year at +9.3% and robust margin performance, though revenue growth remains tepid at +2.1%.
How the stock reacted
Stock surged 7.3% on earnings day (July 21) and continued to gain, up 1.8% three days later to $172.62.
What changed
3M beat Q2 EPS by 5.7% (actual $2.40 vs $2.27 est).
What the price now assumes
Accelerating turnaround, supported by 7.3% surge and forward P/E 40% below sector.
What it means for the business
Upgrade bias. watch next quarter's organic growth and debt reduction progress.
The next one to three months, as we saw it then
Better case30%
Turnaround gains further traction with accelerating organic growth and debt reduction, driving analyst upgrades.
Base case50%
Steady improvement continues with modest EPS growth and stable margins, but valuation remains constrained by leverage.
Worse case20%
Macro headwinds or legal overhang (PFAS) disrupts turnaround, leading to margin compression and multiple de-rating.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.